A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors

Clinical trial NCT05784597 · COMPLETED

Trial details

NCT number: NCT05784597
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Oesophageal Cancer Pancreas Adenocarcinoma

Start date: 2023-04-27
Primary completion: 2024-10-21
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.